Cytosorbents Crp (CTSO)vsStryker Corporation (SYK)
CTSO
Cytosorbents Crp
$0.39
-5.94%
HEALTHCARE · Cap: $22.75M
SYK
Stryker Corporation
$313.39
+4.20%
HEALTHCARE · Cap: $127.55B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 67830% more annual revenue ($25.27B vs $37.20M). SYK leads profitability with a 13.2% profit margin vs -31.9%. SYK earns a higher WallStSmart Score of 55/100 (C-).
CTSO
Avoid24
out of 100
Grade: F
SYK
Buy55
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CTSO.
Margin of Safety
-49.0%
Fair Value
$223.22
Current Price
$313.39
$90.17 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Large-cap with strong market position
Areas to Watch
Trading at 9.8x book value
1.6% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Expensive relative to growth rate
Premium valuation, high expectations priced in
2.6% revenue growth
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : CTSO
CTSO has a balanced fundamental profile.
Bull Case : SYK
The strongest argument for SYK centers on Market Cap.
Bear Case : CTSO
The primary concerns for CTSO are Price/Book, Revenue Growth, EPS Growth. Debt-to-equity of 8.64 is elevated, increasing financial risk.
Bear Case : SYK
The primary concerns for SYK are PEG Ratio, P/E Ratio, Revenue Growth.
Key Dynamics to Monitor
CTSO profiles as a turnaround stock while SYK is a value play — different risk/reward profiles.
CTSO carries more volatility with a beta of 1.36 — expect wider price swings.
SYK is growing revenue faster at 2.6% — sustainability is the question.
SYK generates stronger free cash flow (415M), providing more financial flexibility.
Bottom Line
SYK scores higher overall (55/100 vs 24/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cytosorbents Crp
HEALTHCARE · MEDICAL DEVICES · USA
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?